Resveratrol.com

Canadian scientists at the University of Alberta have discovered Resveratrol can prevent metabolic syndrome – including diabetes and stomach fat - from developing later in life. 

Specifically, the scientists fed resveratrol to recently born mice who struggled to develop in their mother’s wombs. Amazingly, the resveratrol fed mice did not develop metabolic syndrome, including diabetes and excess fat around the stomach (Note: in an earlier study these same scientists demonstrated that mice who struggle to grow in utero often develop metabolic syndrome later in life).

The scientists theorized that resveratrol fed to recently born human children who struggled to develop in their mother’s wombs could help prevent metabolic syndrome later in life. 

Editor’s Note: Resveratrol has already been shown treat Type II diabetes in humans. These new findings indicate resveratrol might be able to prevent Type II diabetes altogether, if given within a certain “window” after birth. This result would be very welcome considering US obesity rates continue to explode. For instance, a recent study published in the medical journal The Lancet projected that a whopping 50% of men and 52% of women may be obese by 2030 (up from 32% and 35%, respectively, in 2008). If that projection holds true, Type II diabetes, along with cancer and heart disease would likely explode – further increasing the nation’s healthcare costs.   For its part, resveratrol also is a powerful anticancer agent and helps to prevent heart disease.